A qualitative study of the perceptions and experiences of participants and healthcare professionals in the Diabetes Remission Clinical Trial (DiRECT)‐Australia type 2 diabetes remission service
Authors' conclusion
Both participants and HCPs were highly interested in the new diabetes remission service set up in an Australian primary care setting. The acceptability of DiRECT-Australia was underscored by participants emphasising the effectiveness of the service in achieving significant weight loss and diabetes remission. There is a need for long-term and wider implementation of the service to ensure that anyone with recent onset type 2 diabetes is offered the best possible chance to achieve remission.
Study context
- Population
- Participants and healthcare professionals (HCPs) delivering the DiRECT-Australia T2D Remission Service, Australian primary care
- Participants
- 8 vs 6
- Comparison
- Participants vs HCPs
- Participantsn = 8
- HCPsn = 6
- Outcome
- Perceptions and experiences of DiRECT-Australia
Methodological detailssemi-structured interviews, online videoconferencing, thematic analysis
- Semi-structured interviews
- Online videoconferencing
- Thematic analysis
Main finding
As reported in the abstract
- Theme 1: Enablers and barriers to recruitment and continuous participation
- Theme 2: Motivators and overcoming barriers across total diet replacement, food reintroduction and weight maintenance phases
- Theme 3: Importance of participant-HCP interactions and continuous support
- Theme 4: Acceptance and long-term need for DiRECT-Australia
- Adherence to total diet replacement was less challenging than anticipated by participants
- Transition to food reintroduction was difficult but overcome through HCP support
- Well accepted by participants and HCPs; participants willing to continue if provided long-term
- Four overarching themes
Original publication
A qualitative study of the perceptions and experiences of participants and healthcare professionals in the DiRECT‐Australia type 2 diabetes remission service. Diabet Med. Published 4 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →